4
Changes in Ownership
MYRIAD GENETICS INC Filed Acc 0001219036-21-000008
Chief Scientific Officer sold 19,360 shares at $31.97 ($618,949)
- Chief Scientific Officer acquired 19,360 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
LANCHBURY JERRY S · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-05-04 | Exercise or conversion : show line 1 in the form | +19,360 | $19.47 | $376,939 | 285,282 | D |
| 2021-05-04 | Sale : show line 2 in the form | −19,360 | $31.97 | $618,949 | 265,922 | D |
| Open-market sales · 19,360 sh · avg $31.97 · $618,949 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-05-04 | Exercise or conversion : show line 3 in the form Non-Qualified Stock Option (right to buy) | −19,360 | 68,640 | D |
Loading xslF345X03/edgardoc.xml…